MarketCapTrends
LGND
Ligand Pharmaceuticals Inc. (LGND)
NASDAQ · Healthcare

Ligand Pharmaceuticals Inc. Cash on Hand 2009–2025

Ligand Pharmaceuticals Inc. annual/quarterly cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Ligand Pharmaceuticals Inc. cash on hand for the quarter ending December 31, 2025 were 174.9M, a 141.92% increase year-over-year.
  • Ligand Pharmaceuticals Inc. cash on hand for 2025 were 174.9M, a 141.92% increase from 2024.
  • Ligand Pharmaceuticals Inc. cash on hand for 2024 were 72.3M, a 215.01% increase from 2023.
  • Ligand Pharmaceuticals Inc. cash on hand for 2023 were 23.0M, a 49.00% decrease from 2022.
  • Ligand Pharmaceuticals Inc. cash on hand for 2022 were 45.0M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Ligand Pharmaceuticals Inc. Annual Cash on Hand (Millions of US $)
2025$175
2024$72
2023$23
2022$45
2021$20
2020$48
2019$72
2018$117
2017$21
2016$19
2015$97
2014$160
2013$12
2012$12
2011$7
Ligand Pharmaceuticals Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$175
2024-12-31$72
2023-12-31$23
2022-12-31$45
2021-12-31$20
2020-12-31$48
2019-12-31$72
2018-12-31$117
2017-12-31$21
2016-12-31$19
2015-12-31$97
2014-12-31$160
2013-12-31$12
2012-12-31$12
2011-12-31$7
2010-12-31$3

Ligand Pharmaceuticals Inc. Cash on Hand — FAQ

Ligand Pharmaceuticals Inc. (LGND) cash on hand over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see LGND's cash on hand history?

The chart and table above show Ligand Pharmaceuticals Inc.'s cash on hand by year and by quarter, including the growth rate.